hotspot -WSS

hotspot

author：focus 2025-09-30 23:19:07 - browse：4

Chris O'Meara/AP

Johnson & Johnson faces a consequential new class action lawsuit — not in its role as a manufacturer of drugs, but as an employer and purchaser of prescription drugs for its workers.

Ann Lewandowski, a health care policy and advocacy director at J&J, sued her company on Monday for allegedly overpaying its pharmacy benefit manager for its employees’ medicines, citing previous STAT reporting to support some of the allegations. Those overpayments, the lawsuit alleges, ultimately come out of workers’ paychecks in the form of high health insurance premiums, higher out-of-pocket drug costs, and stunted wage growth.

In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a generic medicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Donald Trump's relentless attacks on special counsel Jack Smith

Wikipedia

WSS

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

The science behind Janet Jackson's pregnancy at 49

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

Trump Jan. 6 attorney John Lauro is ex

The science behind Janet Jackson's pregnancy at 49

Biden will tout long

knowledge

hotspot

Wikipedia

Medical records are filled with copy

Death of patient in Alzheimer’s trial raises question of possible risks

DIEP, the 'gold standard' of breast reconstruction, is under threat

WATCH: Why do fingernails fall off when they're damaged?

State Dept. review finds Biden bears some blame for Afghanistan failures

Why we need to separate burnout from moral injury in health care

State Dept. review finds Biden bears some blame for Afghanistan failures

Why workplace violence is so common in health care

FDA approval of Sarepta Duchenne genetic therapy gives me hope

With FDA staff opposed to Sarepta therapy, top official intervened

knowledge

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

Mississippi candidates for statewide offices square off in party primaries

The science behind Janet Jackson's pregnancy at 49

Disclosing genetic information: not as worrisome as once feared

Ask STAT: What do you want to know about ChatGPT in medicine?

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

entertainment

focus

Wikipedia

hotspot